Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 48 min ago
PreprintCC BY-NC-NDmedRxiv

The timeline of brain aging in major depression: A prospective study from before first-onset to established illness

29 more authors
  1. 1Institute for Machine Learning in Medicine with focus area psychiatry

Abstract

Major depressive disorder (MDD) has been associated with accelerated structural brain aging, yet whether this reflects a pre-existing neurobiological vulnerability, a dynamic acute state effect, or an accumulating biological residual remains unresolved. Across two longitudinal cohorts (N=3220), including a unique sample of 78 initially healthy individuals who transitioned into their first depressive episode during the study course, we systematically tested all three hypotheses. Patients with diagnosed MDD showed elevated MRI-derived brain age relative to healthy controls (1.4 and 2.5 years across cohorts). For the vulnerability hypothesis, individuals scanned prior to their first episode showed no baseline elevation, despite already demonstrating subclinical elevations in self-reported symptom severity, indicating that advanced brain age does not precede illness onset. For the state hypothesis, we found no acceleration of brain aging following the first depressive episode, and longitudinal brain age trajectories were independent of acute clinical symptom severity. Finally, neither episode duration nor recurrence scaled with brain age. Accelerated brain aging in depression is therefore neither an antecedent vulnerability nor an acute state marker of the first episode, but rather a stable biological feature of a long term illness course.

Related

  1. Alcohol Use Trajectories Across Disasters: Associations With Depression and Illness Anxiety
    Lynsay Ayer, Samer Atshan, Rachana Seelam +4
    Alcohol, clinical & experimental researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. The gasdermin family in depression-associated neuroinflammation: established evidence, emerging mechanisms, and therapeutic perspectives
    Yang Luo, Ziming Liu, Huiqin Li +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  3. Emergency Department Pediatric Early Warning System for Identifying Resuscitation-Defined Critical Illness in Children: A Prospective Diagnostic Classification Study in Vietnam
    Duy Ngoc Le, Vu Duc Bui, Tung Viet Cao +2
    Pediatric reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Dimension-Specific Childhood Maltreatment and Cross-Sectional Markers of Illness Burden in Treatment-Resistant Depression: A Retrospective Single-Center Study
    Giacomo d’Andrea, Luca Persico, Arianna Rosati +13
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossrefEurope PMC
  5. High Mortality in Adults With Community-Acquired Pneumonia Admitted to Hospitals in South Africa Before and During the COVID-19 Pandemic, Stratified by HIV Serostatus and Viral Load: Data From a Prospective Cohort Study (2019–2021)
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{konowski2026timeline,
  title = {{The timeline of brain aging in major depression: A prospective study from before first-onset to established illness}},
  author = {M. Konowski and A. Kraus and J. Goltermann and J. Ernsting and K. Mahjoory and L. Fisch and J. Spanagel and S. Wellms and D. Bedir and L. Altegoer and T. Borgers and S. Teckentrup and S. Papenbrock and A. S. Hildebrand and E. Ratnalingam and E. Meisenzahl and F. Herrmann and S. Meinert and E. J. Leehr and J. Hubbert and J. Krieger and H. Meinert and H. Meinert and T. Slump and I. Nenadic and A. Jansen and N. Javaheripour and F. Thomas-Odenthal and H. Jamalabadai and B. Straube and M. Hermesdorf and M. Richter and R. Helbok and X. Jiang and N. Opel and K. Berger and T. Kircher and U. Dannlowski and T. Hahn and N. R. Winter and R. Leenings},
  howpublished = {medRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.29.26361710},
  url = {https://www.medrxiv.org/content/10.64898/2026.08.29.26361710v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - The timeline of brain aging in major depression: A prospective study from before first-onset to established illness
AU  - M. Konowski
AU  - A. Kraus
AU  - J. Goltermann
AU  - J. Ernsting
AU  - K. Mahjoory
AU  - L. Fisch
AU  - J. Spanagel
AU  - S. Wellms
AU  - D. Bedir
AU  - L. Altegoer
AU  - T. Borgers
AU  - S. Teckentrup
AU  - S. Papenbrock
AU  - A. S. Hildebrand
AU  - E. Ratnalingam
AU  - E. Meisenzahl
AU  - F. Herrmann
AU  - S. Meinert
AU  - E. J. Leehr
AU  - J. Hubbert
AU  - J. Krieger
AU  - H. Meinert
AU  - H. Meinert
AU  - T. Slump
AU  - I. Nenadic
AU  - A. Jansen
AU  - N. Javaheripour
AU  - F. Thomas-Odenthal
AU  - H. Jamalabadai
AU  - B. Straube
AU  - M. Hermesdorf
AU  - M. Richter
AU  - R. Helbok
AU  - X. Jiang
AU  - N. Opel
AU  - K. Berger
AU  - T. Kircher
AU  - U. Dannlowski
AU  - T. Hahn
AU  - N. R. Winter
AU  - R. Leenings
PY  - 2026
DA  - 2026/08/29
PB  - medRxiv
DO  - 10.64898/2026.08.29.26361710
UR  - https://www.medrxiv.org/content/10.64898/2026.08.29.26361710v1
AB  - Major depressive disorder (MDD) has been associated with accelerated structural brain aging, yet whether this reflects a pre-existing neurobiological vulnerability, a dynamic acute state effect, or an accumulating biological residual remains unresolved. Across two longitudinal cohorts (N=3220), including a unique sample of 78 initially healthy individuals who transitioned into their first depressive episode during the study course, we systematically tested all three hypotheses. Patients with diagnosed MDD showed elevated MRI-derived brain age relative to healthy controls (1.4 and 2.5 years across cohorts). For the vulnerability hypothesis, individuals scanned prior to their first episode showed no baseline elevation, despite already demonstrating subclinical elevations in self-reported symptom severity, indicating that advanced brain age does not precede illness onset. For the state hypothesis, we found no acceleration of brain aging following the first depressive episode, and longitudinal brain age trajectories were independent of acute clinical symptom severity. Finally, neither episode duration nor recurrence scaled with brain age. Accelerated brain aging in depression is therefore neither an antecedent vulnerability nor an acute state marker of the first episode, but rather a stable biological feature of a long term illness course.
ER  -